Parkinson's Disease: Leveraging Wearable DHTs

Clinical development in Parkinson's disease is hindered by the high variability within and across patients. Wearable digital health technologies (DHTs) present an opportunity to address this challenge by providing objective, continuous data to complement traditional outcome assessments. In a recent webinar, Address Unmet Measurement Needs In Parkinson's Disease With Wearable DHTs, Dr. Fatta Nahab and Karen Krieger discussed the challenges of Parkinson's disease research and the potential of wearable DHTs to improve measurement quality. They emphasized the importance of objective measures to capture symptom fluctuations and enhance the accuracy of clinical trials. With the use of wearable DHTs, researchers can significantly enhance the efficiency and effectiveness of Parkinson's disease clinical trials, leading to more accurate and meaningful outcomes.